Navigation Links
HEALTHPOINT-Sponsored Venous Leg Ulcer Clinical Trial Enrolls First Subject for Second Phase II Study
Date:6/16/2009

Multi-Center, Randomized Trial to Test Unique Delivery System Using Living Cells to Enhance Wound Healing Marks Milestone for Fort Worth, Texas-based Specialty Biopharmaceutical Company

FORT WORTH, Texas, June 16 /PRNewswire/ -- HEALTHPOINT, Ltd. today announced that it has enrolled the first of a planned 235 subjects into a Phase II dose response study investigating an experimental, cell-based wound therapy ---HP802-247---intended for the treatment of venous leg ulcers. HP802-247 is a topical spray containing living keratinocytes and fibroblasts. The first patient was enrolled at The Center for Clinical Research near San Francisco, Calif., led by the site's principal investigator, Alexander Reyzelman, DPM. The study is being conducted by 28 investigators in 18 states.

"The start of enrollment into this multi-center, randomized trial is an important milestone for HEALTHPOINT," said Bert Slade, M.D., FAAAAI, Chief Medical Officer at HEALTHPOINT and co-author of the trial protocol. "This is the largest cell therapy dose ranging trial ever undertaken in the area of wound healing."

The trial is the second of two planned-dose response trials, extending the dose range being tested and exploring two plausible dose frequencies. Enrollment into the trial is preceded by screening and run-in phases and is expected to continue through the middle of 2010. The first trial showed promising results over a four-fold range of cell concentrations administered weekly.

This trial is evaluating the benefits and safety of enhancing wound healing by using metabolically active donor cells to support the patient's own skin cells' healing ability. HP802-247 utilizes allogeneic cells, which are living human cells derived from an individual donor that are subsequently grown in a tissue culture, and then applied to an unrelated patient. The HP802-247 product consists of both keratinocytes and fibrobl
'/>"/>

SOURCE HEALTHPOINT, Ltd.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. Calixa Therapeutics Announces Positive Phase 1 Results for CXA-101, a Novel Intravenous Cephalosporin Antibiotic with Excellent Anti-Pseudomonal Activity
2. Healthpoint Initiates Phase II, Dose-Finding Study to Evaluate Effectiveness of a Unique Cell Based Therapy in Venous Leg Ulcers
3. MEDIHONEY(TM) Dressings Shown to Help Improve Outcomes of Non-Healing Venous Leg Ulcers in Recent Case Series
4. Pivotal Phase III Data Confirm the Efficacy and Safety of Arpidas Intravenous Iclaprim in Treating Patients With Complicated Skin and Skin Structure Infections
5. Jennerex Completes the Treatment of First Patient Cohort in Phase 1 Trial With Intravenous Delivery of JX-594 Oncolytic Virus
6. Arpida Completes Enrolment in Phase II "Intravenous-to-Oral" Switch Trial With Oral Iclaprim
7. Wound Management Technologies, Inc. Announces Agreement for Evidence Based Study for Diabetic Venous Ulcers
8. Randomized Controlled Clinical Trial Shows Derma Sciences MEDIHONEY(TM) Eradicates MRSA From Chronic Venous Ulcers
9. Phase I/II Study of Targeted Gene Delivery In Vivo - Intravenous Infusions of REXIN-G - Demonstrates Dose-Dependent Anti-Tumor Activity Without Toxicity in Patients With Progressive Chemo-Resistant Bone and Soft Tissue Sarcoma (ASCO 2008)
10. TARGETED GENE DELIVERY SIGNALS CANCER VACCINATION IN VIVO: Intravenous Infusions of Rexin-G Followed by Reximmune-C Induce Tumor Necrosis and Recruitment of Tumor Infiltrating Lymphocytes in Cancerous Lesions (ASCO 2008)
11. Arpida Enrols First Patients in "Intravenous-to-Oral" Switch Trial With Oral Iclaprim
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/4/2015)... May 4, 2015 Unchained Labs, a refreshingly ... this year,s PEGS conference and launches the UNit — ... biologics. PEGS: The Essential Protein Engineering Summit takes place ... The UNit lets drug discovery researchers look ... out there. Its 7 applications, 144 sample a day ...
(Date:5/4/2015)...  Geneia, a company of experienced healthcare change ... healthcare efficiencies, today announced a first-of-its-kind partnership with ... use Geneia,s advanced analytics solution coupled with its ... lower the cost of patient care. ... utilization data from multiple sources to create a ...
(Date:5/4/2015)... Ohio , May 4, 2015 The ... Workforce Survey, which confirmed that pharmacy has shifted toward ... as active pharmacists and managers, there is an incredible ... pharmacists in the next decade. In ... leadership site, Essential Insights , Eden Sulzer, ...
Breaking Medicine Technology:Unchained Labs Lets the UNit Loose 2Geneia Launches First-of-its-Kind Partnership to Use Advanced Analytics to Improve the Quality and Cost of Care for Skilled Nursing and Rehabilitation Patients 2Geneia Launches First-of-its-Kind Partnership to Use Advanced Analytics to Improve the Quality and Cost of Care for Skilled Nursing and Rehabilitation Patients 3Cardinal Health Expert Discusses Latest Research On Gender Gap In Pharmacy 2Cardinal Health Expert Discusses Latest Research On Gender Gap In Pharmacy 3
... Therapeutics, Inc. (Nasdaq: OREX ), a biopharmaceutical company ... financial results for the three months ended September 30, ... 2009 , As of September 30, 2009, Orexigen ... an additional $50.9 million in investment securities, available-for-sale. ...
... , FRANKLIN, Mass., Nov. 4 Echo Therapeutics, Inc. ... the needle-free Symphony(TM) tCGM System as a non-invasive, wireless, ... SkinPrep System for transdermal drug delivery announced today that ... Transdermal Continuous Glucose Monitoring System (tCGM System) in patients ...
Cached Medicine Technology:Orexigen(R) Therapeutics Announces Third Quarter 2009 Financial Results 2Orexigen(R) Therapeutics Announces Third Quarter 2009 Financial Results 3Orexigen(R) Therapeutics Announces Third Quarter 2009 Financial Results 4Orexigen(R) Therapeutics Announces Third Quarter 2009 Financial Results 5Orexigen(R) Therapeutics Announces Third Quarter 2009 Financial Results 6Orexigen(R) Therapeutics Announces Third Quarter 2009 Financial Results 7Orexigen(R) Therapeutics Announces Third Quarter 2009 Financial Results 8Orexigen(R) Therapeutics Announces Third Quarter 2009 Financial Results 9Orexigen(R) Therapeutics Announces Third Quarter 2009 Financial Results 10Echo Therapeutics Initiates Clinical Study of its New One-Piece Symphony(TM) tCGM Biosensor in Type 1 and Type 2 Diabetic Patients 2Echo Therapeutics Initiates Clinical Study of its New One-Piece Symphony(TM) tCGM Biosensor in Type 1 and Type 2 Diabetic Patients 3
(Date:5/4/2015)... 04, 2015 World T.E.A.M. Sports’ best-attended ... ride in the last decade arrived in this historic ... in two days from the Pentagon in Arlington, Virginia. ... registered disabled and able-bodied participants work together to successfully ... and honors the commitment and sacrifices by military veterans ...
(Date:5/4/2015)... May 04, 2015 Scanmarket, a leading ... has been included in the just-released Spend Matters “50 ... the Spend Matters " 50 To Know " listing ... of Scanmarket’s commitment to providing comprehensive, easy-to-use strategic sourcing ... Nielsen, “There are many well-established and respected companies on ...
(Date:5/4/2015)... Fast on the heels of Autism Awareness ... Allison Folmar, JD, join over 150 speakers in the ... Sunday, May 24, the conference presents "I Know You're ... interested in Ryan Hinds' recovery story? The book ... autism was written by Marcia Hinds, Ryan’s mom. ...
(Date:5/4/2015)... Texas (PRWEB) May 04, 2015 Peacock ... about our mothers. He said, “My mother was the most ... Day, wrap her in lovely, feminine prints and textures ... , Look no further than the Eloise Robe to get ... feel with its cap sleeve and tapered waist. It is ...
(Date:5/4/2015)... Diego, CA (PRWEB) May 04, 2015 ... New Cireson Platform to strengthen ... Cireson offers customers a choice to consume Microsoft System ... or Hyper-V on premise , Company transitioning ... model , Continuous innovation with expanding new ...
Breaking Medicine News(10 mins):Health News:Gettysburg Welcomes Arriving Face of America Riders with Gala Celebration 2Health News:Gettysburg Welcomes Arriving Face of America Riders with Gala Celebration 3Health News:Gettysburg Welcomes Arriving Face of America Riders with Gala Celebration 4Health News:Scanmarket Selected to Spend Matters "50 To Know" List of Companies in Procurement Sector. 2Health News:Perhaps the most important information families touched by autism will ever hear is available this month at international conference in Chicago 2Health News:Perhaps the most important information families touched by autism will ever hear is available this month at international conference in Chicago 3Health News:Perhaps the most important information families touched by autism will ever hear is available this month at international conference in Chicago 4Health News:Feminine Classics for Mother's Day Gifts from Peacock Alley 2Health News:Cireson Unveils New Microsoft Cloud & System Center Strategy 2Health News:Cireson Unveils New Microsoft Cloud & System Center Strategy 3Health News:Cireson Unveils New Microsoft Cloud & System Center Strategy 4
... aware of the prevalence of mental health issues and ... we to help the many people who contend with ... of the Canadian Journal of Psychiatry have ... and substance use services to adequately address the needs ...
... donated eggs to fertility clinics reported satisfaction with the ... and 20 percent reported lasting psychological effects, according to ... donation. , The research by scientists at the University ... in 20 states and is the largest study to ...
... LifeBanc, the nonprofit,organ and tissue recovery organization for Northeast ... conference announcing the first,near total face transplant in the ... The following statement is from LifeBanc Chief Executive Officer ... keeping with LifeBanc,s mission of helping to improve and ...
... Filled More Than 1 Million Prescriptions , ... Services, Inc., a wholly owned subsidiary of the Cystic Fibrosis ... services to the cystic fibrosis (CF) community nationwide. , ... 1988 with one patient, one prescription and a mission to ...
... Dynatronics Corporation (Nasdaq: DYNT ) today ... execution of an agreement with a former director for ... improved corporate profitability. On December 15, 2008, the company ... consulting services through its principal, Mark Crockett. As a ...
... Compliance through Patient Engagement , , ... to improve patient safety and standards compliance, GetWellNetwork, Inc. ... is enabling King,s Daughters Medical Center (KDMC) to meet the ... 16 through GetWellNetwork,s interactive PatientLife System(R) . , ...
Cached Medicine News:Health News:National rates of co-occurring substance use and mental disorders call for better service integration 2Health News:National rates of co-occurring substance use and mental disorders call for better service integration 3Health News:Most women report satisfaction with egg donation; some claim problems 2Health News:Most women report satisfaction with egg donation; some claim problems 3Health News:LifeBanc Assists Cleveland Clinic in First Near Total Face Transplant in the United States 2Health News:Cystic Fibrosis Services Pharmacy Celebrates 20th Anniversary 2Health News:Dynatronics Announces Changes to Board and Launches Operational Improvement Process 2Health News:King's Daughters Medical Center Leverages Unique Bedside Interactive Technology to Meet Requirements of Patient Safety Goal 16 2Health News:King's Daughters Medical Center Leverages Unique Bedside Interactive Technology to Meet Requirements of Patient Safety Goal 16 3
... to three conventional measurement modes (Phakic, Aphakic, ... a new axial length measuring mode. Normal ... sonic velocity for conversion at 1550m/s. The ... calculating each tissues sonic velocity for conversion: ...
... A-Scan/Pachymeter with graphic display and IOL ... A-Scan/Pachymeter combination units include firmware module ... Binkhorst II formulas. Audible tones increase ... to visual axis. Constant tone when ...
... the world's first very high frequency digital ... technology, Artemis provides microscopic resolution images and ... anterior segments of the human eye. Artemis ... eye scanner. In use, the patient leans ...
... The ISYSTEM-ABD ("I-cubed") is an ... featuring an analog oscilloscope (static deflection) ... and resolution than low cost video ... hyaloid, syneresis, inflammatory cells, as well ...
Medicine Products: